ID   S22A3_RAT               Reviewed;         551 AA.
AC   O88446;
DT   19-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-OCT-2024, entry version 154.
DE   RecName: Full=Solute carrier family 22 member 3 {ECO:0000250|UniProtKB:O75751};
DE   AltName: Full=Extraneuronal monoamine transporter {ECO:0000303|PubMed:12538837};
DE            Short=EMT {ECO:0000303|PubMed:12538837};
DE   AltName: Full=Organic cation transporter 3 {ECO:0000303|PubMed:9632645};
DE            Short=OCT3 {ECO:0000303|PubMed:9632645};
GN   Name=Slc22a3 {ECO:0000312|RGD:3701}; Synonyms=Oct3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9632645; DOI=10.1074/jbc.273.26.15971;
RA   Kekuda R., Prasad P.D., Wu X., Wang H., Fei Y.-J., Leibach F.H.,
RA   Ganapathy V.;
RT   "Cloning and functional characterization of a potential-sensitive,
RT   polyspecific organic cation transporter (OCT3) most abundantly expressed in
RT   placenta.";
RL   J. Biol. Chem. 273:15971-15979(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND
RP   MISCELLANEOUS.
RC   TISSUE=Placenta;
RX   PubMed=9830022; DOI=10.1074/jbc.273.49.32776;
RA   Wu X., Kekuda R., Huang W., Fei Y.-J., Leibach F.H., Chen J., Conway S.J.,
RA   Ganapathy V.;
RT   "Identity of the organic cation transporter OCT3 as the extraneuronal
RT   monoamine transporter (uptake2) and evidence for the expression of the
RT   transporter in the brain.";
RL   J. Biol. Chem. 273:32776-32786(1998).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MISCELLANEOUS.
RX   PubMed=12538837; DOI=10.1124/jpet.102.044404;
RA   Grundemann D., Hahne C., Berkels R., Schomig E.;
RT   "Agmatine is efficiently transported by non-neuronal monoamine transporters
RT   extraneuronal monoamine transporter (EMT) and organic cation transporter 2
RT   (OCT2).";
RL   J. Pharmacol. Exp. Ther. 304:810-817(2003).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15817714; DOI=10.1165/rcmb.2004-0363oc;
RA   Lips K.S., Volk C., Schmitt B.M., Pfeil U., Arndt P., Miska D., Ermert L.,
RA   Kummer W., Koepsell H.;
RT   "Polyspecific cation transporters mediate luminal release of acetylcholine
RT   from bronchial epithelium.";
RL   Am. J. Respir. Cell Mol. Biol. 33:79-88(2005).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE
RP   SPECIFICITY, AND MISCELLANEOUS.
RX   PubMed=16581093; DOI=10.1016/j.neuropharm.2006.01.005;
RA   Amphoux A., Vialou V., Drescher E., Bruess M., Mannoury La Cour C.,
RA   Rochat C., Millan M.J., Giros B., Boenisch H., Gautron S.;
RT   "Differential pharmacological in vitro properties of organic cation
RT   transporters and regional distribution in rat brain.";
RL   Neuropharmacology 50:941-952(2006).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17616214; DOI=10.1021/mp070023l;
RA   Maeda T., Goto A., Kobayashi D., Tamai I.;
RT   "Transport of organic cations across the blood-testis barrier.";
RL   Mol. Pharm. 4:600-607(2007).
RN   [7]
RP   MISCELLANEOUS.
RX   PubMed=18513366; DOI=10.1111/j.1471-4159.2008.05506.x;
RA   Vialou V., Balasse L., Callebert J., Launay J.M., Giros B., Gautron S.;
RT   "Altered aminergic neurotransmission in the brain of organic cation
RT   transporter 3-deficient mice.";
RL   J. Neurochem. 106:1471-1482(2008).
RN   [8]
RP   FUNCTION, AND MISCELLANEOUS.
RX   PubMed=19416912; DOI=10.1073/pnas.0900358106;
RA   Cui M., Aras R., Christian W.V., Rappold P.M., Hatwar M., Panza J.,
RA   Jackson-Lewis V., Javitch J.A., Ballatori N., Przedborski S., Tieu K.;
RT   "The organic cation transporter-3 is a pivotal modulator of
RT   neurodegeneration in the nigrostriatal dopaminergic pathway.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:8043-8048(2009).
RN   [9]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND MISCELLANEOUS.
RX   PubMed=23458604; DOI=10.1021/mp400024d;
RA   Sala-Rabanal M., Li D.C., Dake G.R., Kurata H.T., Inyushin M.,
RA   Skatchkov S.N., Nichols C.G.;
RT   "Polyamine transport by the polyspecific organic cation transporters OCT1,
RT   OCT2, and OCT3.";
RL   Mol. Pharm. 10:1450-1458(2013).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=27659446; DOI=10.1007/s00429-016-1315-9;
RA   Gasser P.J., Hurley M.M., Chan J., Pickel V.M.;
RT   "Organic cation transporter 3 (OCT3) is localized to intracellular and
RT   surface membranes in select glial and neuronal cells within the basolateral
RT   amygdaloid complex of both rats and mice.";
RL   Brain Struct. Funct. 222:1913-1928(2017).
CC   -!- FUNCTION: Electrogenic voltage-dependent transporter that mediates the
CC       transport of a variety of organic cations such as endogenous bioactive
CC       amines, cationic drugs and xenobiotics (PubMed:12538837,
CC       PubMed:16581093, PubMed:23458604, PubMed:9830022). Cation cellular
CC       uptake or release is driven by the electrochemical potential, i.e.
CC       membrane potential and concentration gradient (PubMed:9632645,
CC       PubMed:9830022). Functions as a Na(+)- and Cl(-)-independent,
CC       bidirectional uniporter (PubMed:9830022). Implicated in neuronal
CC       monoamine neurotransmitters cellular uptake such as dopamine,
CC       adrenaline/epinephrine, noradrenaline/norepinephrine, histamine,
CC       serotonin and tyramine, thereby supporting a role in homeostatic
CC       regulation of aminergic neurotransmission in the brain
CC       (PubMed:16581093, PubMed:19416912, PubMed:9830022). Transports
CC       dopaminergic neuromodulators cyclo(his-pro) and salsolinol with low
CC       efficiency (By similarity). May be involved in the uptake and
CC       disposition of cationic compounds by renal clearance from the blood
CC       flow (By similarity). May contribute to regulate the transport of
CC       cationic compounds in testis across the blood-testis-barrier
CC       (PubMed:17616214). Mediates the transport of polyamine spermidine and
CC       putrescine (PubMed:12538837, PubMed:23458604). Mediates the
CC       bidirectional transport of polyamine agmatine (PubMed:12538837). Also
CC       transports guanidine (PubMed:9632645). May also mediate intracellular
CC       transport of organic cations, thereby playing a role in amine
CC       metabolism and intracellular signaling (PubMed:27659446).
CC       {ECO:0000250|UniProtKB:O75751, ECO:0000269|PubMed:12538837,
CC       ECO:0000269|PubMed:16581093, ECO:0000269|PubMed:17616214,
CC       ECO:0000269|PubMed:19416912, ECO:0000269|PubMed:23458604,
CC       ECO:0000269|PubMed:27659446, ECO:0000269|PubMed:9632645,
CC       ECO:0000269|PubMed:9830022}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-noradrenaline(out) = (R)-noradrenaline(in);
CC         Xref=Rhea:RHEA:73871, ChEBI:CHEBI:72587;
CC         Evidence={ECO:0000269|PubMed:16581093};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-adrenaline(out) = (R)-adrenaline(in);
CC         Xref=Rhea:RHEA:73875, ChEBI:CHEBI:71406;
CC         Evidence={ECO:0000269|PubMed:16581093};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=serotonin(out) = serotonin(in); Xref=Rhea:RHEA:73867,
CC         ChEBI:CHEBI:350546; Evidence={ECO:0000269|PubMed:16581093};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dopamine(out) = dopamine(in); Xref=Rhea:RHEA:73863,
CC         ChEBI:CHEBI:59905; Evidence={ECO:0000269|PubMed:16581093,
CC         ECO:0000269|PubMed:9830022};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=histamine(out) = histamine(in); Xref=Rhea:RHEA:73879,
CC         ChEBI:CHEBI:58432; Evidence={ECO:0000269|PubMed:16581093};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tyramine(in) = tyramine(out); Xref=Rhea:RHEA:74783,
CC         ChEBI:CHEBI:327995; Evidence={ECO:0000250|UniProtKB:O75751};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanidine(out) = guanidine(in); Xref=Rhea:RHEA:73883,
CC         ChEBI:CHEBI:30087; Evidence={ECO:0000250|UniProtKB:O75751};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=agmatine(out) = agmatine(in); Xref=Rhea:RHEA:72131,
CC         ChEBI:CHEBI:58145; Evidence={ECO:0000269|PubMed:12538837};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=spermidine(in) = spermidine(out); Xref=Rhea:RHEA:35039,
CC         ChEBI:CHEBI:57834; Evidence={ECO:0000305|PubMed:23458604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-histidyl-L-proline diketopiperazine(in) = L-histidyl-L-
CC         proline diketopiperazine(out); Xref=Rhea:RHEA:74787,
CC         ChEBI:CHEBI:90039; Evidence={ECO:0000250|UniProtKB:O75751};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-salsolinol(in) = (R)-salsolinol(out);
CC         Xref=Rhea:RHEA:74791, ChEBI:CHEBI:194082;
CC         Evidence={ECO:0000250|UniProtKB:O75751};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=500 uM for serotonin {ECO:0000269|PubMed:16581093};
CC         KM=900 uM for agmatine {ECO:0000269|PubMed:12538837};
CC         KM=1900 uM for noradrenaline {ECO:0000269|PubMed:16581093};
CC         KM=1500 uM for adrenaline {ECO:0000269|PubMed:16581093};
CC         KM=1500 uM for dopamine {ECO:0000269|PubMed:16581093};
CC         KM=5400 uM for histamine {ECO:0000269|PubMed:16581093};
CC         Vmax=8.3 nmol/min/mg enzyme for agmatine uptake
CC         {ECO:0000269|PubMed:12538837};
CC       pH dependence:
CC         Optimum pH is 8.5 for MPP(+) uptake (PubMed:9830022). Optimum pH is
CC         8.5 for TEA uptake (PubMed:9632645). {ECO:0000269|PubMed:9632645,
CC         ECO:0000269|PubMed:9830022};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:27659446};
CC       Multi-pass membrane protein {ECO:0000305}. Apical cell membrane
CC       {ECO:0000269|PubMed:15817714}; Multi-pass membrane protein
CC       {ECO:0000305}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:O75751}; Multi-pass membrane protein
CC       {ECO:0000305}. Mitochondrion membrane {ECO:0000269|PubMed:27659446}.
CC       Endomembrane system {ECO:0000269|PubMed:27659446}. Nucleus membrane
CC       {ECO:0000305|PubMed:27659446}. Nucleus outer membrane
CC       {ECO:0000305|PubMed:27659446}. Note=Localized to neuronal and glial
CC       plasma membranes (PubMed:27659446). Localized to the luminal/apical
CC       membrane of ciliated and brush epithelial cells in the airway
CC       (PubMed:15817714). Located to neuronal and glial endomembranes,
CC       including mitochondrial and nuclear membranes (PubMed:27659446).
CC       {ECO:0000269|PubMed:15817714, ECO:0000269|PubMed:27659446}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta (PubMed:9632645,
CC       PubMed:9830022). Expressed in intestine, hear, kidney and lung
CC       (PubMed:9632645). Widely expressed in brain, particularly in
CC       hippocampus, cerebellum, cerebral cortex (PubMed:9632645,
CC       PubMed:9830022). In the brain, expressed predominantly in regions
CC       located at the brain-cerebrospinal fluid border, with expression
CC       extending to regions that belong to monoaminergic pathways such as
CC       raphe nuclei, striatum and thalamus (PubMed:16581093). In brain,
CC       expressed in neurons and glial cells of amygdala (PubMed:27659446).
CC       Expression is low in kidney and lung and undetectable in liver.
CC       Expressed in Sertoli cells in testis (PubMed:17616214). Expressed in
CC       tracheal and bronchial epithelium of the respiratory tract, where it
CC       localizes to the apical membrane of ciliated and brush cells, and in
CC       basal cells (PubMed:15817714). {ECO:0000269|PubMed:15817714,
CC       ECO:0000269|PubMed:16581093, ECO:0000269|PubMed:17616214,
CC       ECO:0000269|PubMed:27659446, ECO:0000269|PubMed:9632645,
CC       ECO:0000269|PubMed:9830022}.
CC   -!- DOMAIN: Contains one proline-rich sequence (Pro-Glu-Ser-Pro-Arg) that
CC       is required for transport activity. {ECO:0000250|UniProtKB:O75751}.
CC   -!- MISCELLANEOUS: Mediates the uptake of clinically used drugs including
CC       neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) and platinum-based drug
CC       oxaliplatin (PubMed:12538837, PubMed:16581093, PubMed:18513366,
CC       PubMed:19416912, PubMed:23458604, PubMed:9830022). Plays a role in the
CC       anticancer activity of oxaliplatin and may contribute to antitumor
CC       specificity (By similarity). {ECO:0000250|UniProtKB:O75751,
CC       ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:16581093,
CC       ECO:0000269|PubMed:18513366, ECO:0000269|PubMed:19416912,
CC       ECO:0000269|PubMed:23458604, ECO:0000269|PubMed:9830022}.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1) superfamily.
CC       Organic cation transporter (TC 2.A.1.19) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF055286; AAC40150.1; -; mRNA.
DR   RefSeq; NP_062103.1; NM_019230.1.
DR   AlphaFoldDB; O88446; -.
DR   SMR; O88446; -.
DR   STRING; 10116.ENSRNOP00000029748; -.
DR   BindingDB; O88446; -.
DR   ChEMBL; CHEMBL1770033; -.
DR   TCDB; 2.A.1.19.6; the major facilitator superfamily (mfs).
DR   GlyCosmos; O88446; 5 sites, No reported glycans.
DR   GlyGen; O88446; 5 sites.
DR   PhosphoSitePlus; O88446; -.
DR   PaxDb; 10116-ENSRNOP00000029748; -.
DR   Ensembl; ENSRNOT00000037369.3; ENSRNOP00000029748.2; ENSRNOG00000022946.3.
DR   Ensembl; ENSRNOT00055048168; ENSRNOP00055039629; ENSRNOG00055027821.
DR   Ensembl; ENSRNOT00060016671; ENSRNOP00060013024; ENSRNOG00060009873.
DR   Ensembl; ENSRNOT00065050567; ENSRNOP00065041553; ENSRNOG00065029272.
DR   GeneID; 29504; -.
DR   KEGG; rno:29504; -.
DR   AGR; RGD:3701; -.
DR   CTD; 6581; -.
DR   RGD; 3701; Slc22a3.
DR   eggNOG; KOG0255; Eukaryota.
DR   GeneTree; ENSGT00940000160810; -.
DR   HOGENOM; CLU_001265_33_5_1; -.
DR   InParanoid; O88446; -.
DR   OMA; NYWCRIP; -.
DR   OrthoDB; 1474205at2759; -.
DR   PhylomeDB; O88446; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-RNO-2161517; Abacavir transmembrane transport.
DR   Reactome; R-RNO-549127; Organic cation transport.
DR   PRO; PR:O88446; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000022946; Expressed in thymus and 15 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0012505; C:endomembrane system; IDA:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0005640; C:nuclear outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005330; F:dopamine:sodium symporter activity; IDA:RGD.
DR   GO; GO:0008504; F:monoamine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005326; F:neurotransmitter transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0015101; F:organic cation transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IMP:RGD.
DR   GO; GO:0015606; F:spermidine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0019534; F:toxin transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0022857; F:transmembrane transporter activity; ISO:RGD.
DR   GO; GO:1990748; P:cellular detoxification; ISO:RGD.
DR   GO; GO:0015872; P:dopamine transport; IDA:UniProtKB.
DR   GO; GO:0090494; P:dopamine uptake; ISO:RGD.
DR   GO; GO:0048241; P:epinephrine transport; IDA:UniProtKB.
DR   GO; GO:0051625; P:epinephrine uptake; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0051608; P:histamine transport; IDA:UniProtKB.
DR   GO; GO:0051615; P:histamine uptake; ISO:RGD.
DR   GO; GO:0015844; P:monoamine transport; ISO:RGD.
DR   GO; GO:0015718; P:monocarboxylic acid transport; ISO:RGD.
DR   GO; GO:0006836; P:neurotransmitter transport; ISO:RGD.
DR   GO; GO:0015874; P:norepinephrine transport; IDA:UniProtKB.
DR   GO; GO:0051620; P:norepinephrine uptake; ISO:RGD.
DR   GO; GO:0015711; P:organic anion transport; IDA:ARUK-UCL.
DR   GO; GO:0015695; P:organic cation transport; IDA:RGD.
DR   GO; GO:0015850; P:organic hydroxy compound transport; ISO:RGD.
DR   GO; GO:0015697; P:quaternary ammonium group transport; IMP:RGD.
DR   GO; GO:0032098; P:regulation of appetite; ISO:RGD.
DR   GO; GO:0006837; P:serotonin transport; IDA:UniProtKB.
DR   GO; GO:0051610; P:serotonin uptake; ISO:RGD.
DR   GO; GO:0015848; P:spermidine transport; IDA:UniProtKB.
DR   GO; GO:0042908; P:xenobiotic transport; ISO:RGD.
DR   CDD; cd17379; MFS_SLC22A1_2_3; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004749; Orgcat_transp/SVOP.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   NCBIfam; TIGR00898; 2A0119; 1.
DR   PANTHER; PTHR24064; SOLUTE CARRIER FAMILY 22 MEMBER; 1.
DR   PANTHER; PTHR24064:SF52; SOLUTE CARRIER FAMILY 22 MEMBER 3; 1.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS50850; MFS; 1.
DR   PROSITE; PS00216; SUGAR_TRANSPORT_1; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Ion transport; Membrane; Mitochondrion;
KW   Nucleus; Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..551
FT                   /note="Solute carrier family 22 member 3"
FT                   /id="PRO_0000220505"
FT   TRANSMEM        21..41
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        177..197
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        236..256
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        264..284
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        376..396
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        463..483
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        493..513
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           284..288
FT                   /note="Proline-rich sequence"
FT                   /evidence="ECO:0000250|UniProtKB:O75751"
FT   CARBOHYD        72
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        99
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        114
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        199
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        317
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   551 AA;  61050 MW;  23F0EBC24E4F3DE1 CRC64;
     MPTFDQALRK AGEFGRFQRR VFLLLCLTGV TFAFLFVGVV FLGSQPDYYW CRGPRATALA
     ERCAWSPEEE WNLTTPELHV PAERRGQGHC HRYLLEDTNT SSELSCDPLA AFPNRSAPLV
     PCSGDWRYVE THSTIVSQFD LVCGNAWMLD LTQAILNLGF LAGAFTLGYA ADRYGRLIVY
     LISCFGVGIT GVVVAFAPNF SVFVIFRFLQ GVFGKGAWMT CFVIVTEIVG SKQRRIVGIV
     IQMFFTLGII ILPGIAYFTP SWQGIQLAIS LPSFLFLLYY WVVPESPRWL ITRKQGEKAL
     QILRRVAKCN GKHLSSNYSE ITVTDEEVSN PSCLDLVRTP QMRKCTLILM FAWFTSAVVY
     QGLVMRLGLI GGNLYMDFFI SGLVELPGAL LILLTIERLG RRLPFAASNI VAGVSCLVTA
     FLPEGIPWLR TTVATLGRLG ITMAFEIVYL VNSELYPTTL RNFGVSLCSG LCDFGGIIAP
     FLLFRLAAIW LELPLIIFGI LASVCGGLVM LLPETKGIAL PETVEDVEKL GSSQLHQCGR
     KKKTQVSTSN V
//
